Adaptogenics Health Corp witnessed a single insider purchase totaling 54,000 CAD over the past ninety days. Director Gurinder Sandhu acquired 675,000 shares during late September. This activity follows a significant 233.3% stock price appreciation. No recent earnings report data is available to provide further context regarding these equity movements.